MegMan Performance Booster recalled over undeclared tadalafil
- Recall date
- February 4, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Junp Hydration LLC recalls MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, A…
- Recall number
- D-0557-2022
- FDA classification
- Class I
- Brand / firm
- Junp Hydration LLC
- Sold / distributed
- Product was distributed nationwide in the USA via Amazon Marketplace
Why it was recalled
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88
Get recall alerts
Free email alert whenever Junp Hydration LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Junp Hydration LLC